Bridging the Gap Between a TB Drug and Its Target

See allHide authors and affiliations

Science Translational Medicine  05 Sep 2012:
Vol. 4, Issue 150, pp. 150fs33
DOI: 10.1126/scitranslmed.3004816

You are currently viewing the abstract.

View Full Text


A promising new TB drug cocrystallized with its mycobacterial target provides a platform for structure-based design that will improve TB drug development (Neres et al.).

View Full Text